Nosocomial infections with Acinetobacter baumannii: clinical distribution and drug resistance.

OBJECTIVE To approach the clinical distribution and drug resistance in nosocomial infections with Acinetobacter baumannii(ABA) to provide the scientific evidence for clinical diagnosis and treatment.METHODS Referring to National Rules of Operation in Clinical Laboratory,215 strains of ABA were isolated.Microscan auto-4 was used to identify strains.And the antibiotic susceptibility test was performed by K-B method.The test results were judged according to CLSI 2007.RESULTS The top four of isolated rates were the intensive care unit(23.3%),department of neurology(17.7%),department respiratory medicine(15.8%) and department of tumor(14.4%).The detection rate of ABA from specimen from respiratory tract was the highest,arriving at 72.6%.The antibiotic susceptibility test showed ABA had been resistant to commonly used antibiotics.The resistance rates to imipenem and meropenem were 22.3% and 23.7%,respectively.The isolated rate of pan-resistant stains was 7.4%.CONCLUSIONS Hospitals should think highly of monitoring and controlling of drug resistance in ABA and prevent nosocomial infections with multidrug resistant strains.